Product Name
ATP13A2, Polyclonal Antibody
Full Product Name
ATP13A2 Antibody (C-term)
Product Synonym Names
Probable cation-transporting ATPase 13A2; 363-; ATP13A2; PARK9
Product Gene Name
anti-ATP13A2 antibody
[Similar Products]
Antibody/Peptide Pairs
ATP13A2 peptide (MBS9221919) is used for blocking the activity of ATP13A2 antibody (MBS9203648)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence Positions
1133-1161
3D Structure
ModBase 3D Structure for Q9NQ11
Specificity
This ATP13A2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1133-1161 amino acids from the C-terminal region of human ATP13A2.
Purity/Purification
Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
Form/Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Concentration
Vial Concentration: 0.5 (lot specific)
Antigen Type
Synthetic Peptide
Preparation and Storage
Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-ATP13A2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-ATP13A2 antibody
This gene encodes a member of the P5 subfamily of ATPases
which transports inorganic cations as well as other substrates.
Mutations in this gene are associated with Kufor-Rakeb syndrome
(KRS), also referred to as Parkinson disease 9. Multiple transcript
variants encoding different isoforms have been found for this gene.
Product Categories/Family for anti-ATP13A2 antibody
Metabolism; Neuroscience; Signal Transduction
Applications Tested/Suitable for anti-ATP13A2 antibody
Western Blot (WB), ELISA (EIA)
Application Notes for anti-ATP13A2 antibody
WB~~1:1000
Western Blot (WB) of anti-ATP13A2 antibody
ATP13A2 Antibody (C-term) western blot analysis in U251 cell line lysates (35ug/lane).This demonstrates the ATP13A2 antibody detected the ATP13A2 protein (arrow).

NCBI/Uniprot data below describe general gene information for ATP13A2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001135445.1
[Other Products]
NCBI Related Accession #
HumanNP_001135446.1; NP_071372.1[Other Products]
NCBI GenBank Nucleotide #
NM_001141973.2
[Other Products]
UniProt Primary Accession #
Q9NQ11
[Other Products]
UniProt Secondary Accession #
O75700; Q5JXY1; Q5JXY2; Q6S9Z9[Other Products]
UniProt Related Accession #
Q9NQ11[Other Products]
NCBI Official Full Name
probable cation-transporting ATPase 13A2 isoform 2
NCBI Official Synonym Full Names
ATPase type 13A2
NCBI Official Symbol
ATP13A2??[Similar Products]
NCBI Official Synonym Symbols
CLN12; KRPPD; PARK9; HSA9947
??[Similar Products]
NCBI Protein Information
probable cation-transporting ATPase 13A2
UniProt Protein Name
Probable cation-transporting ATPase 13A2
Protein Family
Probable cation-transporting ATPase
UniProt Gene Name
ATP13A2??[Similar Products]
UniProt Synonym Gene Names
PARK9??[Similar Products]
UniProt Entry Name
AT132_HUMAN
NCBI Summary for ATP13A2
This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
UniProt Comments for ATP13A2
ATP13A2: May play a role in intracellular cation homeostasis and the maintenance of neuronal integrity. Expressed in brain; protein levels are markedly increased in brain from subjects with Parkinson disease and subjects with dementia with Lewy bodies. Detected in pyramidal neurons located throughout the cingulate cortex. In the substantia nigra, it is found in neuromelanin- positive dopaminergic neurons. Belongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type V subfamily. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Transporter, ion channel; Transporter; Hydrolase; Membrane protein, multi-pass; Membrane protein, integral; EC 3.6.3.-
Chromosomal Location of Human Ortholog: 1p36
Cellular Component: lysosomal membrane; lysosome; integral to membrane
Molecular Function: protein binding; metal ion binding; ATPase activity; ATP binding
Biological Process: metabolic process; cation transport
Disease: Kufor-rakeb Syndrome
Product References and Citations for anti-ATP13A2 antibody
Dos Santos, A.V., et al. Neurosci. Lett. 485(2):121-124(2010)
Reetz, K., et al. Neurobiol. Dis. 39(3):402-408(2010)
Schneider, S.A., et al. Mov. Disord. 25(8):979-984(2010)
Okada, Y., et al. Hum. Mol. Genet. 19(11):2303-2312(2010)
Fei, Q.Z., et al. Neurosci. Lett. 475(2):61-63(2010)
Research Articles on ATP13A2
1. This study demonistrated that loss of ATP13A2 causes a specific protein trafficking defect, and that Atp13a2 null mice develop age-related motor dysfunction that is preceded by neuropathological changes.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.